AN INTERNATIONAL, MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY OF THE SAFETY OF MARAVIROC USED WITH OPTIMIZED BACKGROUND THERAPY IN TREATMENT-EXPERIENCED HIV-1 INFECTED PATIENTS
AN INTERNATIONAL, MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY OF THE SAFETY OF MARAVIROC USED WITH OPTIMIZED BACKGROUND THERAPY IN TREATMENT-EXPERIENCED HIV-1 INFECTED PATIENTS
The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.
All patients meeting the study eligibility criteria at participating sites will be invited to participate.
Inclusion Criteria:
Exclusion Criteria:
Washington D.C., District of Columbia 20037, United States
Washington D.C., District of Columbia 20037, United States
Silver Spring, Maryland 20910, United States
Huntington, West Virginia 25701, United States
Vancouver, British Columbia V6Z 2C7, Canada
Dresden, D-01307, Germany
Hamburg, D-20246, Germany
München, D-80336, Germany
Milan, 20142, Italy
Naples, 80135, Italy
Pescara, 65100, Italy